Αρχική World News Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC World News Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC Από Ogkologos - 21 Νοεμβρίου, 2024 1076 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer 29 Ιανουαρίου, 2026 Νέα διαγνωστική μέθοδος για τον καρκίνο, με τη συμβολή της Microsoft 5 Αυγούστου, 2019 Mirvetuximab Soravtansine-gynx Shows a Significant Benefit Over Chemotherapy in Women with... 18 Δεκεμβρίου, 2023 Workout Wednesdays – Chest Exercises Part 1 10 Ιουνίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Enzalutamide Gets Added Approval for Prostate Cancer That Hasn’t Spread Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve Survival Multiple mRNA Vaccines Show Promise for Treating HPV-Related Cancers Identical Twins Find Strength in Shared Breast Cancer Battle After Being...